Facial Injectables Market Players:
- Abbvie Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Medytox
- Galderma
- Sinclair Ltd.
- Merz Pharma
- SciVision Biotech Inc
- NovaCutis, Inc
- Bioplus Co. Ltd
- Suneva Medical
- Ipsen Pharma
The facial injectables market consists of a number of major players who are launching various products in the market which is additionally influencing the market growth. Some of them include:
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of facial injectables is assessed at USD 12.66 billion.
The global facial injectables market size surpassed USD 11.64 billion in 2025 and is projected to witness a CAGR of over 9.7%, crossing USD 29.38 billion revenue by 2035.
The North America facial injectables market is predicted to capture 32% share by 2035, fueled by rising spending on cosmetics and appearance.
Key players in the market include Allergan (AbbVie), Galderma S.A., Merz Pharma GmbH & Co. KGaA, Sinclair Pharma, Teoxane Laboratories, Suneva Medical, Inc., Anika Therapeutics, Inc., BioPlus Co., Ltd., Medytox Inc., Croma-Pharma GmbH.
